AVBP logo
ArriVent BioPharma, Inc.(AVBP)
Last print unknown agoAbout this dataData status
$17.94▲1.28 (7.68%)Stale · unknown old

AVBP EV to Operating Cash Flow

-4.94×TTM

Retrieved:

AVBP Quarterly EV/OCF
AVBP Quarterly EV/OCF7.14×-66.65×
2022-03-312026-06-30

Source: Financial Modeling Prep (FMP). Quarterly. Dates are period ends; a fiscal year may differ from a calendar year.

AVBP ev to operating cash flow history

Enterprise value to operating cash flow ratio. The available quarterly series contains 18 observations from Mar 31, 2022 to Jun 30, 2026.

Arrivent Biopharma Inc EV to Operating Cash Flow — Quarterly
Period endingEV to Operating Cash Flow
-37.8851×
-23.3464×
-23.757×
-18.4557×
-24.859×
-8.4853×
-50.7988×
-30.9985×
-16.2294×
-15.8988×
-34.8557×
-34.2287×
-59.507×
-30.0043×
-31.8904×
0×
0×
0×

Compare ev to operating cash flow

All AVBP financial metrics · AVBP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.